Class actions threaten industries that deal with the public. If European lawmakers remove the restriction on class-action suits, consumers will be free to file cases. Pharma companies should take heed.
Richard Elks
Advertisement
Articles by Richard Elks
Advertisement
Latest Updated Articles
Legal: Jumping the PondPublished: September 1st 2005 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
3
FDA Approves Hernexeos Under National Priority Voucher Program
4
Pharmaceutical Executive Daily: FDA Approves Hernexeos
5